article thumbnail

Envision acquires commercial solutions firm Two Labs

pharmaphorum

Scientific communications company Envision Pharma has bought Two Labs, a firm specialising in commercial solutions for the pharma and biotech sector, for an undisclosed sum. The acquisition followed an investment in Envision by specialist European fund Global Healthcare Opportunities (GHO) earlier this month.

article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

The FDA Law Blog

The closest FDA has come is in a 2003 preamble noting that patents that claim finished dosage forms—which can include “metered aerosols, capsules, metered sprays, gels, and pre-filled drug delivery systems”—should be listed in the Orange Book, suggesting that a patent that claims both the drug substance and the delivery device should be listed.

FDA 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Naltrexone interactions to avoid

The Checkup by Singlecare

Communicating openly with your healthcare team about all medical conditions you have and medications you take is the best way to identify potential naltrexone interactions. Keeping open communication with your healthcare provider ensures proper management and monitoring of your health.

article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part iv)

pharmaphorum

There were screening recommendations back in 2003 and they have yet to be fully implemented. Korenjak philosophically entered the conversation with the comparison of the water jug on the table before him: he was thirsty, but he couldn’t reach the water, and a similar experience is what is happening in Europe, he said.

article thumbnail

Paediatric oral compounding: expert insights from a global study

Hospital Pharmacy Europe

Furthermore, it is imperative to raise physician awareness of the practice of compounding and ensure communication between physicians and pharmacists to achieve accurate paediatric prescribing. Concerns were also raised about formulations that use excipients with safety issues, such as ethanol, propylene glycol and parabens.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. Litigation & controversy. CEO Alex Gorsky, who was appointed in 2012.

Vaccines 126
article thumbnail

Jim White, MD

Blog: Ask a Student Pharmacist

Dr. White values the importance of communication between providers and patients in relation to quality care. Outstanding patient care requires great communication. 2003 Nov 11;61(9):1218-21. White JR, Walczak TS, Leppik IE, Rarick J, Tran T, Beniak TE, Matchinsky DJ, Gumnit RJ. doi: 10.1212/01.wnl.0000091865.46063.67.